<DOC>
	<DOCNO>NCT00043420</DOCNO>
	<brief_summary>To assess effect CPG 7909 Injection Cutaneous T-cell lymphoma safety CPG 7909 Injection patient cancer .</brief_summary>
	<brief_title>CPG 7909 Patients With Cutaneous T-Cell Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Lymphoma , T-Cell , Cutaneous</mesh_term>
	<criteria>Patients 18 year old biopsy ( histopathologically ) confirm cutaneous Tcell lymphoma ( limited mycosis fungoides ( MF ) ) prior therapy least one 3 systemic treatment . Patients visceral involvement , serious infection illness include human immunodeficiency virus infection , Karnofsky Performance Status ( KPS ) &lt; 60 exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>immunotherapy , lymphoma</keyword>
</DOC>